[go: up one dir, main page]

NO20012538D0 - Anvendelse av N-substituerte azabicycloalkanderivater for behandling av forstyrrelser i sentralnervesystemet - Google Patents

Anvendelse av N-substituerte azabicycloalkanderivater for behandling av forstyrrelser i sentralnervesystemet

Info

Publication number
NO20012538D0
NO20012538D0 NO20012538A NO20012538A NO20012538D0 NO 20012538 D0 NO20012538 D0 NO 20012538D0 NO 20012538 A NO20012538 A NO 20012538A NO 20012538 A NO20012538 A NO 20012538A NO 20012538 D0 NO20012538 D0 NO 20012538D0
Authority
NO
Norway
Prior art keywords
treatment
nervous system
central nervous
system disorders
azabicycloalkane derivatives
Prior art date
Application number
NO20012538A
Other languages
English (en)
Other versions
NO20012538L (no
Inventor
Rainer Munschauer
Gerd Steiner
Gerhard Gross
Martin Traut
Liliane Unger
Hans-Juergen Teschendorf
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of NO20012538D0 publication Critical patent/NO20012538D0/no
Publication of NO20012538L publication Critical patent/NO20012538L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Indole Compounds (AREA)
NO20012538A 1998-11-24 2001-05-23 Anvendelse av N-substituerte azabicycloalkanderivater for behandling av forstyrrelser i sentralnervesystemet NO20012538L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19854147A DE19854147A1 (de) 1998-11-24 1998-11-24 Verwendung von N-substituierten Azabicycloalkan-Derivaten zur Verwendung bei der Bekämpfung der Cocainsucht
PCT/EP1999/008734 WO2000030639A1 (de) 1998-11-24 1999-11-12 Verwendung von n-substituierten azabicycloalkan-derivaten zur behandlung von erkrankungen des zentralen nervensystems

Publications (2)

Publication Number Publication Date
NO20012538D0 true NO20012538D0 (no) 2001-05-23
NO20012538L NO20012538L (no) 2001-07-04

Family

ID=7888824

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20012538A NO20012538L (no) 1998-11-24 2001-05-23 Anvendelse av N-substituerte azabicycloalkanderivater for behandling av forstyrrelser i sentralnervesystemet

Country Status (21)

Country Link
EP (1) EP1133293A1 (no)
JP (1) JP2002530333A (no)
KR (1) KR20010080535A (no)
CN (1) CN1328455A (no)
AR (1) AR021502A1 (no)
AU (1) AU1775300A (no)
BG (1) BG105549A (no)
BR (1) BR9915589A (no)
CA (1) CA2352526A1 (no)
CZ (1) CZ20011796A3 (no)
DE (1) DE19854147A1 (no)
HK (1) HK1040933A1 (no)
HR (1) HRP20010472A2 (no)
HU (1) HUP0104416A3 (no)
IL (1) IL143181A0 (no)
NO (1) NO20012538L (no)
PL (1) PL348758A1 (no)
SK (1) SK7112001A3 (no)
TR (1) TR200101476T2 (no)
WO (1) WO2000030639A1 (no)
ZA (1) ZA200103976B (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0519013A2 (pt) 2004-12-13 2009-11-03 Lilly Co Eli composto ou esteroisÈmeros únicos, misturas de esteroisÈmeros, sais, tautÈmeros ou pró-drogas destes farmaceuticamente aceitáveis, composição farmacêutica, e, uso de um composto
GB0812310D0 (en) 2008-07-03 2008-08-13 Syngenta Ltd Novel herbicides
WO2014111837A1 (en) * 2013-01-15 2014-07-24 Novartis Ag Use of alpha 7 nicotinic acetylcholine receptor agonists

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2717288A (en) * 1987-11-12 1989-06-01 American Home Products Corporation Polycyclicamines with psychotropic activity
DE4427648A1 (de) * 1994-08-04 1996-02-08 Basf Ag N-Stubstituierte 3-Azabicyclo[3,2,0,]heptan-Derivate, ihre Herstellung und Verwendung
DE4341403A1 (de) * 1993-12-04 1995-06-08 Basf Ag N-substituierte 3-Azabicycloalkan-Derivate, ihre Herstellung und Verwendung
DE4427647A1 (de) * 1994-08-04 1996-02-08 Basf Ag N-substituierte Azabicycloheptan-Derivate, ihre Herstellung und Verwendung

Also Published As

Publication number Publication date
KR20010080535A (ko) 2001-08-22
DE19854147A1 (de) 2000-05-25
CN1328455A (zh) 2001-12-26
IL143181A0 (en) 2002-04-21
WO2000030639A1 (de) 2000-06-02
HRP20010472A2 (en) 2003-04-30
HK1040933A1 (zh) 2002-06-28
JP2002530333A (ja) 2002-09-17
AR021502A1 (es) 2002-07-24
SK7112001A3 (en) 2001-12-03
CZ20011796A3 (cs) 2002-05-15
CA2352526A1 (en) 2000-06-02
ZA200103976B (en) 2002-05-16
BG105549A (en) 2001-12-29
NO20012538L (no) 2001-07-04
TR200101476T2 (tr) 2001-10-22
PL348758A1 (en) 2002-06-03
HUP0104416A3 (en) 2002-11-28
EP1133293A1 (de) 2001-09-19
HUP0104416A2 (hu) 2002-04-29
AU1775300A (en) 2000-06-13
BR9915589A (pt) 2001-08-07

Similar Documents

Publication Publication Date Title
DE69925571D1 (de) Sulphonamid-derivate zur behandlung von störungen des zentralnervensystems
NO20005884L (no) Kombinasjonsterapi for behandling av bipolare forstyrrelser
IS6377A (is) Pýrrólidínasetamíð afleiður einar sér eða í samsetningu til meðhöndlunar á truflunum í miðtaugakerfi
EE04280B1 (et) Imidasopürimidiinid ja imidasopüridiinid neuroloogiliste häirete käitlemiseks
IL155589A0 (en) Novel amidoalkyl-piperidine and amidoalkyl-piperazine derivatives useful for the treatment of nervous system disorders
NO20026263L (no) Sulfonyl-pyrrolidin-derivater anvendelige for behandling av neurologiske forstyrrelser
NO20043085L (no) Fremgangsmater og sammensetninger for behandling av forstyrrelser i sentralnervesystemet
PL350679A1 (en) Derivatives of 1-arenosulphonyl-2-arylpyrolydine and piperidine for treating central nervous system disorders
EE200000391A (et) Triasiiniühendid kesknärvisüsteemihäirete raviks
ID27214A (id) Triazolopiridina untuk pengobatan gangguan trombosis
FI971527A7 (fi) Indolijohdannaisten käyttö erilaisten sairauksien hoitoon
ATE256126T1 (de) 5-heteroatom-alkyl substituierte 3-oxo-pyrido(1,2-a)benzimidazol-4-carboxamid derivate zur behandlung zentral nervöser system störungen
ATE292107T1 (de) Verwendung von carbonylaminoderivaten gegen zentralnervensystem-störungen
DE69735417D1 (de) 2,5-dihydroxybenzylsulfonderivate zur behandlung von sexuellen störungen
NO991734D0 (no) Pyrazolinoner for behandling av potensforstyrrelser
NO20011892D0 (no) 3-tetrahydropyridin-4-yl-indoler for behandling av psykotiske forstyrrelser
DE69923464D1 (de) Benzenesulfonamide derivate in kombination mit beta-blockern zur behandlung von störungen des autonomen nervensystems
ATE374197T1 (de) Indolderivate zur behandlung von erkrankungen des zentralnervensystems
NO20012538D0 (no) Anvendelse av N-substituerte azabicycloalkanderivater for behandling av forstyrrelser i sentralnervesystemet
NO20010390D0 (no) Behandling av angstsykdommer
NO20012612D0 (no) Isonipecotamider for behandling av integren-formidlede lidelser
IS2172B (is) Indól afleiður sem eru nytsamlegar fyrir meðhöndlun á taugakerfistruflunum
NO20014026L (no) Krampestillende derivater til behandling av betydelig skjelving
DE60026848D1 (de) C-6 ringsubstituierte pyridoä1,2-aübenzimidazolderivate zur behandlung von störungen des zentralen nervensystems
UA25221A (uk) Спосіб лікуваhhя розладів цеhтральhої hервової системи

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application